Nuvalent NUVL
NUVL
$123.96 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Nuvalent (NUVL) Retained Earnings (2020 - 2026)

Nuvalent's (NUVL) quarterly Retained Earnings came in at -$1.4 million in Q1 2026, up 99.79% YoY from -$678227.5 in Q1 2025, and up 99.86% on a QoQ basis from -$972.4 million in Q4 2025.

Analysis

Nuvalent (NUVL) Retained Earnings (2020 - 2026) Analysis & Trends

Nuvalent (NUVL) has 7 years of Retained Earnings data on file, last reported at -$1.4 million in Q1 2026.

  • Quarterly Retained Earnings rose 99.79% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 99.79% YoY) and the FY2025 annual result came in at -$972.4 million, down 77.76% from the prior year.
  • Retained Earnings climbed to -$1.4 million in Q1 2026, from -$972.4 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $1.4 million in Q2 2025 to a low of -$972.4 million in Q4 2025.
  • A 5-year average of -$287.4 million and a median of -$214.4 million in 2023 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2023 — Retained Earnings plunged 57854.66% — and 2025, when it soared 100.35%.
  • Tracing NUVL's Retained Earnings over 5 years: stood at -$494000.0 in 2022, then sank by 57854.66% to -$286.3 million in 2023, then sank by 91.08% to -$547.1 million in 2024, then slumped by 77.76% to -$972.4 million in 2025, then soared by 99.86% to -$1.4 million in 2026.
  • The last three Retained Earnings figures came in at -$1.4 million (Q1 2026), -$972.4 million (Q4 2025), and -$853.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Nuvalent 9.75 Bn 9.75 Bn - -1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.10 Bn
Dec 31, 2025 -972.43 Mn
Sep 30, 2025 -853.72 Mn
Jun 30, 2025 -731.30 Mn
Mar 31, 2025 -631.63 Mn
Dec 31, 2024 -547.05 Mn
Sep 30, 2024 -472.30 Mn
Jun 30, 2024 -387.94 Mn
Mar 31, 2024 -330.80 Mn
Dec 31, 2023 -286.30 Mn
Sep 30, 2023 -248.00 Mn
Jun 30, 2023 -214.40 Mn
Mar 31, 2023 -185.30 Mn
Dec 31, 2022 -160.08 Mn
Sep 30, 2022 -134.00 Mn
Jun 30, 2022 -114.24 Mn
Mar 31, 2022 -95.80 Mn
Dec 31, 2021 -78.22 Mn
Sep 30, 2021 -60.93 Mn
Jun 30, 2021 -48.51 Mn